Catalyst Says FDA Is Breaking Law By Approving Rival's Drug
Catalyst Pharmaceuticals Inc. fought Tuesday against a federal judge's determination that the U.S. Food and Drug Administration lawfully approved a lower-cost version of a drug that treats a rare autoimmune disease,...To view the full article, register now.
Already a subscriber? Click here to view full article